The Form 4 filing, an SEC report of insider share activity, was filed on Nov. 12, 2026. It lists Jack W. Schuler as a 10% owner and emeritus director. The purchase took place on Nov. 10, two days before the filing date.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-10 |
| Date of Latest Transaction | 2026-11-10 |
| Buy/Sell | buy |
| Transaction Count | 1 |
| Shares Transacted | 100,000 |
| Price | $10.02 |
| Total Transaction Value | $1,001,990.00 |
| Insider | |
| Ticker Symbol | BDSX |
| Company | BIODESIX INC |
| Insider Name | SCHULER JACK W |
| Insider Title | 10% Owner, Other, Emeritus Director |
| Sector - Industry | Healthcare - Diagnostics & Research |
| Holdings | |
| Total Shares Owned After Transaction | 655,810 |
| Position Size Change | 15.25% |
| Filing | |
| Filing Date | 2026-11-12 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
This was a purchase of 100,000 BDSX shares, reported with transaction code P. That code identifies a purchase. The filing lists one transaction.
What was the average price of the transaction?
The average price was $10.0199 per share. Rounded to the nearest cent, that is $10.02, the price shown in the transaction table.
How did this transaction affect the insider's holdings?
Jack W. Schuler reported owning 655,810 shares after the purchase. The 100,000 shares he bought made up 15.25% of the shares he reported owning afterward.
What's the total transaction value?
The total value was $1,001,990.00 for the single reported purchase. That amount covers all 100,000 shares bought in the transaction.
Are there any special circumstances around this transaction?
The available transaction information did not identify a special arrangement. Filing footnote text was not available, so any additional terms or explanations remain unknown. The available details do not establish why he made the purchase.
For research purposes only; not investment advice.